Inventor · Lund, SE

Peter Ellmark

19Patents

4h-index

26Co-inventors

56Inventor score

Filing activity: Nov 17, 2010 → Nov 4, 2022

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9486520B2	Compositions comprising polyglutamic acid nanoparticles and CD40 agonists	Human Necessities	9	Active
US9676862B2	Anti-CD40 antibodies and methods of treating cancer	Chemistry; Metallurgy	8	Active
US10414815B2	scFV antibody library	Chemistry; Metallurgy	7	Active
US10239949B2	Oncofetal antigen binding proteins and related compositions and methods	Chemistry; Metallurgy	4	Active
US10689454B2	Anti-CD137 antibodies and uses thereof	Physics	3	Active
US11008396B2	Polypeptides	Chemistry; Metallurgy	2	Active
US11312786B2	Oncofetal antigen binding proteins and related compositions and methods	Chemistry; Metallurgy	1	Active
US11873348B2	Peptides	Chemistry; Metallurgy	1	Active
US10577425B2	Anti-CD40 antibodies	Chemistry; Metallurgy	0	Active
US9834589B2	CD86 variants with improved affinity for CTLA-4	Physics	0	Active
US11780928B2	Polypeptides	Chemistry; Metallurgy	0	Active
US11535678B2	Anti-CD137 antibodies and uses thereof	Physics	0	Active
US11725060B2	Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods	Chemistry; Metallurgy	0	Active
US12415862B2	Methods and compositions	Chemistry; Metallurgy	0	Active
US10640567B2	Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cells	Chemistry; Metallurgy	0	Active
US8685640B2	Medical methods and agents for use therein	Physics	0	Active
US10774150B2	Polypeptides	Chemistry; Metallurgy	0	Active
US12173082B2	Bispecific polypeptides against CD137	Chemistry; Metallurgy	0	Active
US11149090B2	Combination therapies with anti CD40 antibodies	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.